YD Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	6.01	3.13	0.09
Cash & Short-Term Investments	6.01	3.13	0.09
Cash Growth	91.80%	3496.29%	-
Accounts Receivable	0.46	0.1	0.1
Inventory	1.88	0.04	0.07
Other Current Assets	1.32	0.19	0.02
Total Current Assets	9.67	3.47	0.27
Net Property, Plant & Equipment	0.07	0.09	0.01
Other Intangible Assets	2.61	2.68	-
Long-Term Investments	-	-	0.01
Other Long-Term Assets	1.43	0.63	0.02
Total Assets	13.78	6.86	0.32
Accounts Payable	0.41	0.03	0.02
Accrued Expenses	0.44	0.18	0.02
Current Portion of Long-Term Debt	-	-	0.03
Current Portion of Leases	0.01	0.02	0.01
Other Current Liabilities	0.79	0.04	0.22
Total Current Liabilities	1.64	0.26	0.3
Long-Term Leases	-	0.01	-
Other Long-Term Liabilities	14.99	0.01	-
Total Long-Term Liabilities	14.99	0.01	-
Total Liabilities	16.64	0.27	0.3
Common Stock	0.01	0.01	0.11
Additional Paid-in Capital	7.16	8.47	0.39
Accumulated Other Comprehensive Income	0.21	0.05	0.05
Retained Earnings	-10.24	-1.93	-0.52
Shareholders' Equity	-2.86	6.59	0.02
Total Liabilities & Equity	13.78	6.86	0.32
Total Debt	0.01	0.02	0.05
Net Cash (Debt)	6	3.11	0.04
Net Cash Growth	92.95%	7769.11%	-
Net Cash Per Share	0.09	0.05	0.00
Book Value	-2.86	6.59	0.02
Book Value Per Share	-0.04	0.10	0.00
Tangible Book Value	-5.47	3.91	0.02
Tangible Book Value Per Share	-0.08	0.06	0.00

SEC Filings: 10-K · 10-Q